Intelligence / Healthtech / New Clinical Trials / Merck Sharp & Dohme LLC
Clinicaltrial registered5 Nov 2026
Merck Sharp & Dohme LLC
5 Nov 2026: Trial registered · A Clinical Trial of MK-7602 in Healthy Volunteers (MK-7602-006). Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 5 Nov 2026
- Title
- A Clinical Trial of MK-7602 in Healthy Volunteers (MK-7602-006)
- Conditions
- Healthy
- Phase
- Phase 1
- Study Type
- Interventional
- Status
- Not Yet Recruiting
- Reference
- NCT07919028
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Merck Sharp & Dohme LLC
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Across AOS Research
Other records for Merck Sharp & Dohme LLC in our registers.
16 NovMerck Sharp & Dohme LLCtrial registered · HealthtechClinical6 NovMerck Sharp & Dohme LLCtrial registered · HealthtechClinical5 NovMerck Sharp & Dohme LLCtrial registered · HealthtechClinical2 NovMerck Sharp & Dohme LLCtrial registered · HealthtechClinical2 NovMerck Sharp & Dohme LLCtrial registered · HealthtechClinical28 OctMerck Sharp & Dohme LLCtrial registered · HealthtechClinical26 OctMerck Sharp & Dohme LLCtrial registered · HealthtechClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.